These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 33233014)

  • 1. Association between changes in urine output and successful indomethacin treatment for patent ductus arteriosus in preterm neonates.
    Louis D; Dey A; Jain A
    J Paediatr Child Health; 2021 Apr; 57(4):554-558. PubMed ID: 33233014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of the efficacy and safety of paracetamol, ibuprofen, and indomethacin in closure of patent ductus arteriosus in preterm neonates.
    El-Mashad AE; El-Mahdy H; El Amrousy D; Elgendy M
    Eur J Pediatr; 2017 Feb; 176(2):233-240. PubMed ID: 28004188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants.
    Ohlsson A; Walia R; Shah S
    Cochrane Database Syst Rev; 2008 Jan; (1):CD003481. PubMed ID: 18254020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ibuprofen for the treatment of a patent ductus arteriosus in preterm and/or low birth weight infants.
    Ohlsson A; Walia R; Shah S
    Cochrane Database Syst Rev; 2003; (2):CD003481. PubMed ID: 12804469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants.
    Ohlsson A; Walia R; Shah S
    Cochrane Database Syst Rev; 2005 Oct; (4):CD003481. PubMed ID: 16235321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of ibuprofen versus indomethacin in preterm infants treated for patent ductus arteriosus: a randomised controlled trial.
    Lago P; Bettiol T; Salvadori S; Pitassi I; Vianello A; Chiandetti L; Saia OS
    Eur J Pediatr; 2002 Apr; 161(4):202-7. PubMed ID: 12014386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of Therapeutic Response to Cyclooxygenase Inhibitors in Preterm Infants with Patent Ductus Arteriosus.
    Hu Y; Jin H; Jiang Y; Du J
    Pediatr Cardiol; 2018 Apr; 39(4):647-652. PubMed ID: 29468349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants.
    Su PH; Chen JY; Su CM; Huang TC; Lee HS
    Pediatr Int; 2003 Dec; 45(6):665-70. PubMed ID: 14651538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus.
    Van Overmeire B; Smets K; Lecoutere D; Van de Broek H; Weyler J; Degroote K; Langhendries JP
    N Engl J Med; 2000 Sep; 343(10):674-81. PubMed ID: 10974130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of oral ibuprofen with oral indomethacin for PDA closure in Indian preterm neonates: a randomized controlled trial.
    Yadav S; Agarwal S; Maria A; Dudeja A; Dubey NK; Anand P; Yadav DK
    Pediatr Cardiol; 2014 Jun; 35(5):824-30. PubMed ID: 24435507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants.
    Ohlsson A; Walia R; Shah SS
    Cochrane Database Syst Rev; 2020 Feb; 2(2):CD003481. PubMed ID: 32045960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants.
    Ohlsson A; Walia R; Shah SS
    Cochrane Database Syst Rev; 2015 Feb; (2):CD003481. PubMed ID: 25692606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants.
    Malviya M; Ohlsson A; Shah S
    Cochrane Database Syst Rev; 2008 Jan; (1):CD003951. PubMed ID: 18254035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of the efficacy of ibuprofen and indomethacin in the treatment of patent ductus arteriosus in prematurely born infants].
    Adamska E; Helwich E; Rutkowska M; Zacharska E; Piotrowska A
    Med Wieku Rozwoj; 2005; 9(3 Pt 1):335-54. PubMed ID: 16547381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital.
    Supapannachart S; Limrungsikul A; Khowsathit P
    J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1252-8. PubMed ID: 12549803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants.
    Malviya M; Ohlsson A; Shah S
    Cochrane Database Syst Rev; 2003; (3):CD003951. PubMed ID: 12917997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline cardiac output and its alterations during ibuprofen treatment for patent ductus arteriosus in preterm infants.
    Hsu KH; Wu TW; Wu IH; Lai MY; Hsu SY; Huang HW; Mok TY; Lee CC; Lien R
    BMC Pediatr; 2019 Jun; 19(1):179. PubMed ID: 31167645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants.
    Shah SS; Ohlsson A
    Cochrane Database Syst Rev; 2006 Jan; (1):CD004213. PubMed ID: 16437478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacology of ibuprofen and indomethacin in preterm infants with patent ductus arteriosus.
    Pacifici GM
    Curr Pediatr Rev; 2014; 10(3):216-37. PubMed ID: 25088343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patent ductus arteriosus in preterm neonates.
    Aggarwal R; Bajpai A; Deorari AK; Paul VK
    Indian J Pediatr; 2001 Oct; 68(10):981-4. PubMed ID: 11758138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.